Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance
International Immunopharmacology · 2024-08 · 137 · 112461
DOI: 10.1016/j.intimp.2024.112461 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Zhiwen Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Cisplatin, Wnt Signaling Pathway. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Central South University, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Ovarian cancer (OC) is a gynecological malignancy that results in a global threat to women's lives. Lactic acid, a key metabolite produced from the glycolytic metabolism of glucose molecules, is correlated with tumor immune infiltration and platinum resistance. In our previous study, we found that endothelial cell-specific molecule 1 (ESM1) plays a key role in OC progression. This study revealed that lactate could upregulate ESM1, which enhances SCD1 to attenuate the antitumor CD8+ T-cell response. ESM1 and SCD1 expression levels were significantly greater in OC patients with high lactic acid levels than in those with low lactic acid levels. Further mechanistic studies suggested that the Wnt/β-catenin pathway was inactivated after ESM1 knockdown and rescued by SCD1 overexpression. IC50 analysis indicated that the ESM1-SCD1 axis induces the resistance of OC cells to platinum agents, including cisplatin, carboplatin, and oxaliplatin, by upregulating P-gp. In conclusion, our study indicated that the induction of SCD1 by lactic acid-induced ESM1 can impede the CD8+ T-cell response against tumors and promote resistance to cisplatin by activating the Wnt/β-catenin pathway in ovarian cancer. Consequently, targeting ESM1 may have considerable therapeutic potential for modulating the tumor immune microenvironment and enhancing drug sensitivity in OC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, China.
- Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
- Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China; Hunan Province Key Laboratory of Tumor Cellular &…
- Department of Gynecology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, China. Electronic address: hesili@csu.edu.cn.
- Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. Electronic address: yukun_li@foxmail.com.
Förderung
- National Natural Science Foundation of China
- Central South University
- Natural Science Foundation of Hunan Province
Zitieren
APA
Fan, Z., Ye, M., Liu, D., Zhou, W., Zeng, T., He, S., & Li, Y. (2024). Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. International Immunopharmacology, 137, 112461. https://doi.org/10.1016/j.intimp.2024.112461
Vancouver
Fan Z, Ye M, Liu D, Zhou W, Zeng T, He S, et al. Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. International Immunopharmacology. 2024;137:112461. doi:10.1016/j.intimp.2024.112461
BibTeX
@article{Fan2024,
author = {Fan, Zhiwen and Ye, Mingzhu and Liu, Dan and Zhou, Wenchao and Zeng, Tian and He, Sili and Li, Yukun},
title = {Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance},
journal = {International Immunopharmacology},
year = {2024},
volume = {137},
pages = {112461},
doi = {10.1016/j.intimp.2024.112461}
}
EUVIMED